Lisa Girion


Lisa Girion is a former staff writer at the Los Angeles Times, where she had covered healthcare, the workplace, legal affairs, human rights and the California economy. Prior to coming to The Times, Girion served as city editor of the Los Angeles Daily News and reported for that paper as well the Dallas Times Herald, the Dallas Morning News and the Wilmington (Del.) News Journal. She has won awards for her work, including exposes on alleged human rights abuses in Myanmar (Burma) and on the health insurance practice of rescinding sick members. She earned a bachelor's degree at Northwestern University’s Medill School of Journalism. Girion left The Times in 2015. 

Recent Articles

  • 走向全球的奥施康定——“我们只是刚刚开始”


    在美国, 奥施康定是一桩垂死的生意。 阿片类药物曾在全国迅速蔓延, 夺走超过20万人的生命, 美国医疗机构目前正在减少使用这种止痛药。级卫生官员建议, 初级诊疗医生在治疗慢性疼痛时减少开这种药的处方。他们称, 没有证据表明它长期有效, 且有大量证据表明, 它们为患者带来风险。 奥施康定的处方自2010年起以及下降了近40, 位于康涅狄格州的制药商普渡制药(Purdue Pharma)因此蒙受数以十亿美元计的损失。 该公司的所有者萨克勒(Sackler)家族因此推行了一项新的策略将引起美国阿片类药物危机的止痛药放入世界各地的药柜。 该家族名下的国际公司正在迅速打入拉美、亚洲、中东、非洲和其他地区,...

  • OxyContin goes global: 'We're only just getting started'

    OxyContin goes global: 'We're only just getting started'

    OxyContin is a dying business in America. With the nation in the grip of an opioid epidemic that has claimed more than 200,000 lives, the U.S. medical establishment is turning away from painkillers. Top health officials are discouraging primary care doctors from prescribing them for chronic pain,...